BRKR Bruker Corporation

USD 64.75 0.00 0
Icon

Bruker Corporation (BRKR) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 64.75

0.00 (0.00)%

USD 9.80B

1.06M

USD 82.73(+27.76%)

USD 100.00 (+54.44%)

Icon

BRKR

Bruker Corporation (USD)
COMMON STOCK | NSD
USD 64.75
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 9.80B

USD 100.00 (+54.44%)

USD 64.75

Bruker Corporation (BRKR) Stock Forecast

Show ratings and price targets of :
USD 82.73
(+27.76%)

Based on the Bruker Corporation stock forecast from 6 analysts, the average analyst target price for Bruker Corporation is USD 82.73 over the next 12 months. Bruker Corporation’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Bruker Corporation is Slightly Bullish , which is based on 10 positive signals and 7 negative signals. At the last closing, Bruker Corporation’s stock price was USD 64.75. Bruker Corporation’s stock price has changed by +5.03% over the past week, +0.34% over the past month and -12.61% over the last year.

No recent analyst target price found for Bruker Corporation
No recent average analyst rating found for Bruker Corporation

Company Overview Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scie...Read More

https://www.bruker.com

40 Manning Road, Billerica, MA, United States, 01821

9,707

December

USD

USA

Adjusted Closing Price for Bruker Corporation (BRKR)

Loading...

Unadjusted Closing Price for Bruker Corporation (BRKR)

Loading...

Share Trading Volume for Bruker Corporation Shares

Loading...

Compare Performance of Bruker Corporation Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BRKR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bruker Corporation (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc 0.00 (0.00%) USD45.36B 74.06 57.12

ETFs Containing BRKR

Symbol Name BRKR's Weight Expense Ratio Price(Change) Market Cap
JSMD
Janus Henderson Small/Mid.. 1.88 % 0.30 % 0.00 (0.00%) USD0.35B

Frequently Asked Questions About Bruker Corporation (BRKR) Stock

Based on ratings from 6 analysts Bruker Corporation's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 6 buy, 3 sell and 2 hold ratings.

BRKR stock's dividend yield is 0.31%. Our analysis grades BRKR stock's dividend yield at F. This means that BRKR stock's dividend yield is above 50% of the stocks in the Medical Devices sector in the NSD exchange. Based on this BRKR may be a average dividend stock for its sector.

Based on targets from 6 analysts, the average taret price for BRKR is USD 82.73 over the next 12 months. The maximum analyst target price is USD 102 while the minimum anlayst target price is USD 60.

BRKR stock's Price/Earning ratio is 23.72. Our analysis grades BRKR stock's Price / Earning ratio at F. This means that BRKR stock's Price/Earning ratio is above 56.00000000000001% of the stocks in the Medical Devices sector in the NSD exchange. Based on this BRKR may be a overvalued for its sector.

The last closing price of BRKR's stock was USD 64.75.

The most recent market capitalization for BRKR is USD 9.80B.

Based on targets from 6 analysts, the average taret price for BRKR is projected at USD 82.73 over the next 12 months. This means that BRKR's stock price may go up by +27.76% over the next 12 months.

Following are ETFs with the highest allocation to Bruker Corporation's stock :

JSMD

As per our most recent records Bruker Corporation has 9,707 Employees.

Bruker Corporation's registered address is 40 Manning Road, Billerica, MA, United States, 01821. You can get more information about it from Bruker Corporation's website at https://www.bruker.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...